Codexis, Inc. (CDXS)
NGS · Common · CUSIP 192005106
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for CDXS and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
CUSIP
192005106
Market Cap
Mid Cap
IPO
4/22/2010 · $13.00/share
Business: Codexis, Inc., is a leading protein engineering company that applies its proprietary CodeEvolver® technology to develop proteins for a variety of applications, including as biocatalysts for the commercial manufacture of pharmaceuticals, fine chemicals and industrial enzymes, and enzymes as biotherapeutics and for use in molecular diagnostics. Codexis’ proven technology enables improvements in protein performance, meeting customer needs for rapid, cost-effective and sustainable manufacturing in multiple commercial-scale implementations of biocatalytic processes.
Notes: April 30, 2014, there were 38,660,773 shares

Company Contact

CEO
John Nicols
CFO
Ross Taylor
Headquarters
200 Penobscot Drive, Redwood City, CA 94063
Phone
650-421-8100
Investor Relations
Jody Cain, LHA IR · 310-691-7100 · jcain@lhai.com
General Email
ir@codexis.com
SEC EDGAR Filings
View filings »